0001104659-20-130008.txt : 20201127
0001104659-20-130008.hdr.sgml : 20201127
20201127160257
ACCESSION NUMBER: 0001104659-20-130008
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201117
FILED AS OF DATE: 20201127
DATE AS OF CHANGE: 20201127
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Redmile Group, LLC
CENTRAL INDEX KEY: 0001425738
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36533
FILM NUMBER: 201355326
BUSINESS ADDRESS:
STREET 1: ONE LETTERMAN DRIVE
STREET 2: BUILDING D, SUITE D3-300
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94129
BUSINESS PHONE: 415-489-9980
MAIL ADDRESS:
STREET 1: ONE LETTERMAN DRIVE
STREET 2: BUILDING D, SUITE D3-300
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94129
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Green Jeremy
CENTRAL INDEX KEY: 0001650527
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36533
FILM NUMBER: 201355327
MAIL ADDRESS:
STREET 1: ONE LETTERMAN DRIVE, BUILDING D
STREET 2: SUITE D3-300
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94129
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MedAvail Holdings, Inc.
CENTRAL INDEX KEY: 0001402479
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 900772394
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6665 MILLCREEK DR
STREET 2: UNIT 1
CITY: MISSISSAUGA
STATE: A6
ZIP: L5N 5M4
BUSINESS PHONE: 973-509-0444
MAIL ADDRESS:
STREET 1: 6665 MILLCREEK DR
STREET 2: UNIT 1
CITY: MISSISSAUGA
STATE: A6
ZIP: L5N 5M4
FORMER COMPANY:
FORMER CONFORMED NAME: MYOS RENS TECHNOLOGY INC.
DATE OF NAME CHANGE: 20160322
FORMER COMPANY:
FORMER CONFORMED NAME: MYOS Corp
DATE OF NAME CHANGE: 20120521
FORMER COMPANY:
FORMER CONFORMED NAME: Atlas Therapeutics Corp
DATE OF NAME CHANGE: 20100719
3
1
tm2037152d-1_3.xml
OWNERSHIP DOCUMENT
X0206
3
2020-11-17
0
0001402479
MedAvail Holdings, Inc.
MDVL
0001425738
Redmile Group, LLC
ONE LETTERMAN DRIVE, BUILDING D
SUITE D3-300
SAN FRANCISCO
CA
94129
1
0
1
0
0001650527
Green Jeremy
ONE LETTERMAN DRIVE, BUILDING D
SUITE D3-300
SAN FRANCISCO
CA
94129
1
0
1
0
Common Stock
11724726
I
See Footnote
Warrants to Purchase Shares of Common Stock
2.09
2019-03-04
2029-03-04
Common Stock
73253
I
See Footnote
Warrants to Purchase Shares of Common Stock
2.09
2019-07-23
2029-07-23
Common Stock
87058
I
See Footnote
Warrants to Purchase Shares of Common Stock
1.57
2019-12-19
2029-12-19
Common Stock
54524
I
See Footnote
Warrants to Purchase Shares of Common Stock
1.57
2020-05-26
2030-05-26
Common Stock
74855
I
See Footnote
Warrants to Purchase Shares of Common Stock
1.57
2020-10-06
2030-10-06
Common Stock
15236
I
See Footnote
These securities are directly owned by certain private investment vehicles and separately managed accounts managed by Redmile Group, LLC ("Redmile") and may be deemed beneficially owned by Redmile as investment manager of such private investment vehicles and separately managed accounts. The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
Gerard van Hamel Platerink and Rob Faulkner, members of the board of directors of the Issuer and managing directors of Redmile, were elected to the board of the Issuer as representatives of Redmile. As a result, the Reporting Persons are directors by deputization for purposes of Section 16 of the Securities Exchange Act of 1934, as amended.
The exercise price for the warrant is in Canadian dollars.
By: /s/ Jeremy Green, Managing Member of Redmile Group, LLC
2020-11-27
/s/ Jeremy Green
2020-11-27